References
- Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986;256:3358–3363.
- Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001;137:765–770.
- Lee HY, Tay LK, Thirumoorthy T, Pang SM. Cutaneous adverse drug reactions in hospitalised patients. Singapore Med J 2010;51:767–774.
- Gerson D, Sriganeshan V, Alexis JB. Cutaneous drug eruptions: a 5-year experience. J Am Acad Dermatol 2008;59:995–999.
- Ding YW, Lee KC, Choon ES. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol 2010;49:834–841.
- Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents–a 6 year series from Chandigarh, India. J Postgrad Med 2001;47:95–99.
- Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255–1259.
- Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005;209:123–129.
- Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999;48:839–846.
- Guidelines for the RegiSCAR Study. September 2009. Available at: http://regiscar.uni-freiburg.de
- Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008;74:430.
- Apaydin R, Bilen N, Dökmeci S, Bayramgürler D, Yildirim G. Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital. J Eur Acad Dermatol Venereol 2000;14:518–520.
- Puavilai S, Choonhakarn C. Drug eruptions in Bangkok: a 1-year study at Ramathibodi Hospital. Int J Dermatol 1998;37:747–751.
- Barbaud A, Reichert-Penetrat S, Tréchot P, Jacquin-Petit MA, Ehlinger A, Noirez V et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49–58.
- Hernández-Salazar A, Rosales SP, Rangel-Frausto S, Criollo E, Archer-Dubon C, Orozco-Topete R. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients. Arch Med Res 2006;37:899–902.
- Adısen E, Karaca F, Gurer AM. Dermatolojide ilaç reaksiyonları. J Dermatol 2008;2:1–5.
- Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur J Clin Pharmacol 2011;67:463–470.
- Li LF, Ma C. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China. Clin Exp Dermatol 2006;31:642–647.
- Teraki Y, Shibuya M, Izaki S. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations. Clin Exp Dermatol 2010;35:723–728.
- Huang HY, Luo XQ, Chan LS, Cao ZH, Sun XF, Xu JH. Cutaneous adverse drug reactions in a hospital-based Chinese population. Clin Exp Dermatol 2011;36:135–141.
- Atzori L, Pinna AL, Mantovani L, Ferreli C, Pau M, Mulargia M et al. Cutaneous adverse drug reactions to allopurinol: 10 year observational survey of the dermatology department - cagliari university (Italy). J Eur Acad Dermatol Venereol 2011; Oct 24. [Epub ahead of print].
- Aihara M. Pharmacogenetics of cutaneous adverse drug reactions. J Dermatol 2011;38:246–254.